Factors associated with residual nodal disease among breast cancer patients treated with neoadjuvant chemotherapy: Results of CALGB 40601 (HER2-positive) and 40603 (triple negative) (Alliance)
- Citation:
- Ann Surg Oncol vol 20 (Suppl 1) p S9
- Meeting Instance:
- SSO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3533
- Pharmas:
- GSK, Genentech
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Anna Weiss Jordan Campbell Karla Ballman William Sikov Lisa Carey Shelley Hwang Matthew Poppe Ann Partridge David Ollila Mehra Golshan
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NC010, LAPS-UT003, NY167, RI005
- Study
- Alliance-A151942
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-40601, CALGB-40603
- Phases:
- N/A, 2, 3
- Keywords: